Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Abeona Therapeutics Inc (NASDAQ: ABEO) was $7.36 for the day, down -2.77% from the previous closing price of $7.57. In other words, the price has decreased by $-2.77 from its previous closing price. On the day, 0.78 million shares were traded. ABEO stock price reached its highest trading level at $7.73 during the session, while it also had its lowest trading level at $7.26.
Ratios:
Our analysis of ABEO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.15 and its Current Ratio is at 4.15. In the meantime, Its Debt-to-Equity ratio is 0.36 whereas as Long-Term Debt/Eq ratio is at 0.30.
On September 18, 2020, B. Riley FBR started tracking the stock assigning a Buy rating and target price of $5.
On February 10, 2020, SVB Leerink started tracking the stock assigning a Outperform rating and target price of $6.SVB Leerink initiated its Outperform rating on February 10, 2020, with a $6 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 06 ’24 when Seshadri Vishwas bought 20,000 shares for $4.39 per share. The transaction valued at 87,800 led to the insider holds 528,260 shares of the business.
Alvino Mark sold 7,084 shares of ABEO for $36,199 on Jan 17 ’24. The Director now owns 62,816 shares after completing the transaction at $5.11 per share. On Sep 27 ’23, another insider, Seshadri Vishwas, who serves as the Chief Executive Officer of the company, bought 20,000 shares for $4.07 each. As a result, the insider paid 81,400 and bolstered with 521,731 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABEO now has a Market Capitalization of 201332800 and an Enterprise Value of 160251632. For the stock, the TTM Price-to-Sale (P/S) ratio is 57.53 while its Price-to-Book (P/B) ratio in mrq is 13.17. Its current Enterprise Value per Revenue stands at 45.786 whereas that against EBITDA is -3.49.
Stock Price History:
Over the past 52 weeks, ABEO has reached a high of $9.01, while it has fallen to a 52-week low of $2.83. The 50-Day Moving Average of the stock is -0.76%, while the 200-Day Moving Average is calculated to be 46.04%.
Shares Statistics:
ABEO traded an average of 353.54K shares per day over the past three months and 331130 shares per day over the past ten days. A total of 26.52M shares are outstanding, with a floating share count of 25.91M. Insiders hold about 5.27% of the company’s shares, while institutions hold 51.75% stake in the company. Shares short for ABEO as of 1711584000 were 1994258 with a Short Ratio of 5.64, compared to 1709164800 on 1641973. Therefore, it implies a Short% of Shares Outstanding of 1994258 and a Short% of Float of 7.670000000000001.
Earnings Estimates
The market rating of Abeona Therapeutics Inc (ABEO) is currently shaped by the ongoing analysis conducted by Abeona Therapeutics Inc. analysts closely monitoring its performance.The consensus estimate for the next quarter is $22.52, with high estimates of $3.45 and low estimates of $2.30.
